Citadel Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.33M Buy
800,689
+656,351
+455% +$7.65M ﹤0.01% 1415
2025
Q1
$1.07M Sell
144,338
-82,644
-36% -$614K ﹤0.01% 3208
2024
Q4
$1.36M Buy
226,982
+17,556
+8% +$105K ﹤0.01% 2995
2024
Q3
$1.07M Sell
209,426
-192,696
-48% -$987K ﹤0.01% 3050
2024
Q2
$1.46M Buy
402,122
+320,224
+391% +$1.16M ﹤0.01% 2716
2024
Q1
$263K Buy
81,898
+79,027
+2,753% +$254K ﹤0.01% 4534
2023
Q4
$14.1K Sell
2,871
-141,121
-98% -$691K ﹤0.01% 5463
2023
Q3
$785K Sell
143,992
-570,530
-80% -$3.11M ﹤0.01% 3285
2023
Q2
$4.79M Sell
714,522
-87,981
-11% -$590K ﹤0.01% 1748
2023
Q1
$7.09M Buy
802,503
+259,225
+48% +$2.29M ﹤0.01% 1554
2022
Q4
$4.15M Sell
543,278
-292,537
-35% -$2.23M ﹤0.01% 1950
2022
Q3
$5.95M Buy
835,815
+434,246
+108% +$3.09M ﹤0.01% 1700
2022
Q2
$3.25M Buy
401,569
+199,698
+99% +$1.62M ﹤0.01% 2281
2022
Q1
$2.8M Buy
201,871
+31,851
+19% +$442K ﹤0.01% 2646
2021
Q4
$4.77M Buy
170,020
+43,704
+35% +$1.23M ﹤0.01% 2135
2021
Q3
$4.29M Buy
126,316
+79,813
+172% +$2.71M ﹤0.01% 2176
2021
Q2
$1.9M Sell
46,503
-311,290
-87% -$12.7M ﹤0.01% 3270
2021
Q1
$14.4M Buy
357,793
+352,101
+6,186% +$14.2M ﹤0.01% 1161
2020
Q4
$337K Sell
5,692
-8,161
-59% -$483K ﹤0.01% 4144
2020
Q3
$674K Sell
13,853
-36,887
-73% -$1.79M ﹤0.01% 3242
2020
Q2
$2.46M Buy
50,740
+14,763
+41% +$714K ﹤0.01% 2063
2020
Q1
$999K Sell
35,977
-21,827
-38% -$606K ﹤0.01% 2869
2019
Q4
$1.73M Sell
57,804
-60,279
-51% -$1.8M ﹤0.01% 2499
2019
Q3
$3.65M Sell
118,083
-116,288
-50% -$3.59M ﹤0.01% 1895
2019
Q2
$11.3M Buy
+234,371
New +$11.3M 0.01% 1119